Android app Apple app link

Is Zoetis Inc. (ZTS) the Best Weight Loss Drug Stock to Buy According to Analysts?

By Yahoo! Finance   |   1 month ago
Is Zoetis Inc. (ZTS) the Best Weight Loss Drug Stock to Buy According to Analysts?

The GLP-1 weight loss medication market faces challenges due to high costs and limited insurance coverage, hindering accessibility for obese individuals. Shortages of GLP-1 drugs impact diabetic patients, emphasizing the need for improved access. Zoetis Inc.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.